A Study of ASP3082 in Adults With Advanced Solid Tumors

NCT05382559 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

681

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Setidegrasib
DRUG: Cetuximab
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Fluorouracil
DRUG: Irinotecan
DRUG: Nanoparticle albumin-bound-paclitaxel
DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Pembrolizumab
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Liposomal Irinotecan

Sponsor

Astellas Pharma Inc